Literature DB >> 31908900

Erratum to Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer.

Yuxiang Wang1,2, Xian Li1, Xueling Liu1,2, Yi Chen2,3, Chunhao Yang4, Cun Tan4, Bobo Wang1, Yiming Sun2,3, Xi Zhang1, Yinglei Gao2,3, Jian Ding2,3, Linghua Meng1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31908900      PMCID： PMC6936228          DOI： 10.20892/j.issn.2095-3941.2019.0401

Source DB:  PubMed          Journal:  Cancer Biol Med        ISSN： 2095-3941            Impact factor:   4.248


× No keyword cloud information.
In the published [1], errors appeared in on page 69. In , bands for p-Akt S473, Akt, and Actin in H1355 cells were mistakenly placed. Here, we have updated to correct the mistake above. The errors do not impact the conclusions of this article. We apologize for the errors and for any confusion it may have caused.
1B

NSCLC cells were treated with CYH33 at theindicated concentrations for 1 h. Cell lysates were subjected to Western blot with the indicated antibodies.

NSCLC cells were treated with CYH33 at theindicated concentrations for 1 h. Cell lysates were subjected to Western blot with the indicated antibodies.
  1 in total

1.  Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer.

Authors:  Yuxiang Wang; Xian Li; Xueling Liu; Yi Chen; Chunhao Yang; Cun Tan; Bobo Wang; Yiming Sun; Xi Zhang; Yinglei Gao; Jian Ding; Linghua Meng
Journal:  Cancer Biol Med       Date:  2019-02       Impact factor: 4.248
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.